Comparan-Núñez A, Palacios JM, Jerjes-Sánchez DC

Language: Spanish
References: 19
Page: 61-68
PDF size: 78.88 Kb.

ABSTRACT

In acute phase leukocytes has been related with higher incidence of major adverse cardiovascular events, (MACE) this evidence in AMI ST elevation after mechanical reperfusion is poor. We study prospectively this group to relationship among mechanical reperfusion, leukocytes and MACE. Two groups were considered ‹ 10,000/μL or ›10,000/μL; 271 patients had full inclusion criteria in a 5 year period; 93 had ‹ 10,000/μL leukocytes. (8,300 ± 1,254/μL) and 178 › 10,000/μL. (13,810 ± 3,192/μL, p 0.0001). We did not observe any difference between both groups regarding demographic characteristics. At beginning leukocytosis group had higher flow TIMI 0 – 1 incidence (89% vs 75%, p 0.004) and in – hospital major cardiovascular adverse events (32% vs 14%, p 0.001) and in follow- up (5% vs 2%, p 0.04). Logistic regression model include › 60 years – old, diabetes, extensive anterior or inferior infarction, TIMI flow 0, 1, or 2, cardiogenic shock, leukocytosis and neuthrophilia, had close relationship with mortality (p = 0.0007, RM 1.40, IC 95% 0.410 - 4.841). Multiple regression that include leukocytosis and neuthrophlia had stronger correlation with major cardiovascular adverse events (mortality, r = 0.34 and cardiogenic shock, r = 0.27) and abnormal TIMI flow (r = 0.20). Conclusion: Our results confirm close relationship among leukocitosis, thrombosis and major cardiovascular adverse events and extend this knowledge to acute phase and follow- up in acute myocardial infarction ST elevation under percutaneous coronary intervention. These results could be considered as evidence that connecting between endotelial dysfunction (inflammation-atherothrombosis) and cardiovascular disease.

REFERENCES

1. Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore J, Goldberg R: Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996; 78: 945-948.

2. Lloyd-Jones DM, Camargo Jr CA, Giugliano RP, O’Donnell J: Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina. Am Heart J 2000; 139: 867-873.

3. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E, for the OPUS-TIMI Investigators: Association of with blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 2001; 87: 636-639.

4. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson MC: Association between with blood cell count epicardial blood flow, myocardial perfusion and clinical outcomes in the setting of acute myocardial infarction. Circulation 2000; 102: 2329-2334.

5. Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM: The association between white blood cell count and acute myocardial infarction in patients > 65 years of age: Findings from Cooperative Cardiovascular Project. J Am Coll Cardiol 2001; 38: 1654-1661.

6. Sabatine MS, Morrow DA, Cannon CP, Murphy AS, Demopoulos LA, DiBattiste PM, et al: Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy. J Am Cardiol 2002; 40: 1761-1768.

7. Meisel C, Afshar-Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, et al: Role of kozak sequence polymorphism of platelet glycoprotein Iba as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 2001; 38: 1023-1027.

8. Lopez JA, Dong JF: Structure and function of the glycoprotein Ib – IX – V complex. Curr Opi Hematol 1997; 4: 323-329.

9. Pellizzon GG, Dixon RS, Stone GW, Cox DA, Mattos L, Boura JA, et al: Relation of admission white blood cell count to long - term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial) for the Stent PAMI Investigators. Am Jour Cardiol 2003; 91: 729-731.

10. Friedman GD, Klastsky AL, Siegelaub AB: The leukocyte count as predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-1278.

11. Schlant RC, Forman S, Stamler J, Canner PL: The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2,789 men. The 5-year findings of the Coronary Drug Project. Circulation 1982; 66: 401-414.

12. Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, et al: Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. A TACTICS-TIMI 18 Substudy. J Am Coll Cardiol 2002; 40: 1761-1768.

13. Toss H, Lindahl B, Siegbahn A, Wallentin L, for the FRISC Study Group: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204-4210.

14. Lindmark E, Diderholm E, Wallentin L, Siegbahn A: Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107-2113.

15. Solodky A, Berliner S, Safrir H: Increased adhesiveness for peripheral blood leukocytes corresponds to the appearance of expansion following anterior wall myocardial infarction. Clin Cardiol 1996; 19: 102-103.

16. Anzai T, Yoshikawa T, Shiraki H: C-reactive protein as a predictor or infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997; 96: 778-784.

17. Izaguirre AR, Zaldivar AH: El fibrinógeno como factor de riesgo cardiovascular. Arch Cardiol Mex 2003; 73: 7-10.

18. Koenig W: Fibrinogen in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-609.

19. Pomar FP, Martínez JVA, Peris DE, Echanove EI, Vilar HJV, Pérez FE, et al: Valor pronóstico de la persistencia del segmento ST elevado después de una angioplastía primaria realizada con éxito. Rev Esp Cardiol 2002; 55: 816-822.